GlaxoSmithKline <GSK.L> is partnering with the Wellcome Trust, the world's second-largest medical research charity, to fight hospital "superbugs", the two groups said on Monday.

2000-12-13 04:00:00 PDT London-- The British companies Glaxo Wellcome PLC and SmithKline Beecham PLC said yesterday that they had received initial clearance from U.S. regulators for a long-delayed ...

LONDON — Glaxo Wellcome and SmithKline Beecham completed their merger Wednesday to forge the world’s leading drugs group by market share, nearly three years after the effort began. The new ...

Meyerhoff noted in her review that the drug manufacturer, Glaxo Wellcome Inc., said Raxar played no role in the deaths. ... On Oct. 27, 1999, Glaxo pulled Raxar off the market.

Glaxo Wellcome has already made a $1 million royalty payment and will make an Oct. 23 payment of $7.25 million to cover the University’s legal fees and out-of-pocket expenses. Over a 12-year period, ...

Glaxo Wellcome Inc. is writing to inform you of important revisions to the safety labeling for Relenza (zanamivir for inhalation), which is approved for the treatment of uncomplicated acute ...

LONDON (MarketWatch) -- GlaxoSmithKline PLC GSK and The Wellcome Trust Monday said they plan to develop a new class of antibacterial drugs to combat the rise of hospital-acquired infections, which ...